Plasma Asprosin Concentrations Are Increased in Individuals with Glucose Dysregulation and Correlated with Insulin Resistance and First-Phase Insulin Secretion
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background. Adipokines are reported to participate in many common pathologic processes of glucose dysregulation, such as insulin resistance, β-cell dysfunction, and chronic inflammation. Objective. To detect the concentrations of plasma asprosin in subjects with impaired glucose regulation (IGR) and newly diagnosed type 2 diabetes (nT2DM) and its relationship to parameters of glucose and lipid metabolism, insulin resistance, and pancreatic β-cell function. Methods. 143 eligible participants were included and were divided into three groups including normal glucose regulation (NGR, n=52), IGR (n=40), and nT2DM group (n=51). The intravenous glucose tolerance test (IVGTT) and clinical and biochemical parameters were measured in all participants. Results. Plasma asprosin levels were higher in IGR (82.40 ± 91.06 ng/mL, P<0.001) and nT2DM (73.25 ± 91.69 ng/mL, P<0.001) groups compared with those in the NGR (16.22 ± 9.27 ng/mL) group, especially in IGR subjects. Correlation analysis showed that plasma asprosin levels were positively correlated with waist circumference (Wc), fasting plasma glucose (FPG), postchallenge plasma glucose (2hPG), HbA1c, triglyceride (TG), and homeostasis model assessment for insulin resistance (HOMA-IR) and negatively correlated with homeostasis model assessment for β-cell function (HOMA-β), area under the curve of the first-phase (0–10 min) insulin secretion (AUC), acute insulin response (AIR), and glucose disposition index (GDI) (all P<0.05). Multiple logistical regression analyses revealed that plasma asprosin concentrations were significantly correlated with IGR and nT2DM after controlling for age, sex, BMI, and WHR. Conclusions. Circulating asprosin might be a predictor of early diagnosis in DM and might be a potential therapeutic target for prediabetes and T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“Inflammations are reported to participate in the pathogenesis of DM [14, 15].”
BackgroundIDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · cited 1×
“Impaired glucose regulation (IGR), including both impaired glucose tolerance (IGT) and impaired fasting glycaemia (IFG) [2], has a high risk to develop as DM [3, 4] and shared many common pathologic mechanisms with DM, such as insulin resistance, β-cell dysfunction, and chronic inflammation.”
BackgroundAsprosin, a Fasting-Induced Glucogenic Protein Hormone
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P. K., Del Solar, M., Zhu, B., York, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.063 · Cited by 591 · cited 11×
“In addition, asprosin was reported to activate the G protein-cAMP-PKA axis in the liver [5], which has been demonstrated to have an amelioration effect on chronic inflammation [6, 7].”
BackgroundInfluentialDel Prato, S., & Tiengo, A. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.198 · Cited by 238 · cited 1×
“In addition, pancreatic β-cell malfunction is considered as another important mechanism in the development of T2DM [11, 12], and more and more adipokines have been reported to impact on the function, proliferation, death, and failure of β cell [13].”
BackgroundThe role of adipokines in β-cell failure of type 2 diabetes
Dunmore, S. J., & Brown, J. E. P. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0278 · Cited by 204
Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection
Jiang, J., & Dingledine, R. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.05.003 · Cited by 166
Anti-inflammatory effects of PGE2 in the lung: role of the EP4 receptor subtype
Birrell, M. A., Maher, S. A., Dekkak, B., Jones, V., Wong, S., Brook, P., & Belvisi, M. G. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206592 · Cited by 113 · cited 1×
“In addition, asprosin was reported to activate the G protein-cAMP-PKA axis in the liver [5], which has been demonstrated to have an amelioration effect on chronic inflammation [6, 7].”
BackgroundJu, X., Ijaz, T., Sun, H., LeJeune, W., Vargas, G., Shilagard, T., Recinos, A., Milewicz, D. M., Brasier, A. R., & Tilton, R. G. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000476 · Cited by 91 · cited 1×
“In FBN1 hypomorphic mice (mgR/mgR displayed a 70% decrease in circulating asprosin), proinflammatory cytokines were elevated and contributed to the formation of inflammatory diseases, such as aortic aneurysms [19].”
Background
Cited by
The role of adipokines in health and disease
Clemente-Suárez, V. J., Redondo-Flórez, L., Beltrán-Velasco, A. I., Martín-Rodríguez, A., Martínez-Guardado, I., Navarro-Jiménez, E., Laborde-Cárdenas, C. C., & Tornero-Aguilera, J. F. (2023) · Biomedicines · doi:10.3390/biomedicines11051290 · Cited by 463
Energy regulation mechanism and therapeutic potential of asprosin
Hoffmann, J. G., Xie, W., & Chopra, A. R. (2020) · Diabetes · doi:10.2337/dbi19-0009 · Cited by 52
“The authors also showed that plasma asprosin concentration is positively correlated with patient waist circumference, fasting plasma glucose, HbA1c, triglycerides, impaired glucose regulation, type 2 diabetes, and HOMA for insulin resistance (19).”
BackgroundInfluential
Metadata
- Authors
- Wang, Y., Qu, H., Xiong, X., Qiu, Y., Liao, Y., Chen, Y., Zheng, Y., & Zheng, H.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2018
- Volume
- 2018
- Pages
- 1-7
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- OpenAlex
- W2791782137
- Cited by
- 189
- References
- 18
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.